K2 Principal Fund’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History
Bought
Maintained
Sold
Other funds holding OACC
K2 Principal Fund's OACC Position: Q3 2026 in Review
K2 Principal Fund reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 69% in Q3 2026, selling an estimated $2.7M and leaving 114,779 shares worth $1.23M. The position accounts for 0.1% of the portfolio, ranked #205.
K2 Principal Fund first reported a position in OACC in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.92M in Q2 2026. 47 funds tracked by Wall St. Rank hold OACC as of Q3 2026.
- K2 Principal Fund held 114,779 shares of Oaktree Acquisition Corp III Life Sciences worth $1.23M as of Q3 2026.
- K2 Principal Fund sold 251,121 Oaktree Acquisition Corp III Life Sciences shares in Q3 2026, an estimated $2.7M.
- Oaktree Acquisition Corp III Life Sciences made up 0.1% of K2 Principal Fund's portfolio in Q3 2026, its #205 holding.
- K2 Principal Fund first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 8 quarters since.
- K2 Principal Fund's Oaktree Acquisition Corp III Life Sciences position peaked at $3.92M in Q2 2026.
- 47 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2026.
Based on K2 Principal Fund's 13F filing for Q3 2026, filed 13 Nov 2026.